May 27, 2016 09:35AM Pre-Open Stock Movers 05/27: (RLYP) (TTNP) (FEIX) Higher; (HERO) (UNXL) (TEX) Lower (more...)

Mar 8, 2016 11:41AM Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Sees Strong Results in 2016

Nov 9, 2015 02:20PM TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

Sep 17, 2015 09:34AM Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Ublituximab Combo SPA Validates Study Design

Aug 25, 2015 09:28AM Roth Capital Highlights Biotech Picks 'for the Turn' and Over the Long Haul (PTN) (LGND) (TGTX) (CLDX)

Aug 10, 2015 11:27AM TG Therapeutics (TGTX) Continuing to Drive on All Cylinders; Roth Affirms 'Focus Pick' Rating

Jun 18, 2015 01:19PM TG Therapeutics (TGTX) Data Acts as Strong GENUINE Proxy, Roth Capital Says

May 14, 2015 07:42AM Roth Capital 'Focus Pick' on TG Therapeutics (TGTX) Reiterated Amid ASCO Data

Apr 20, 2015 02:27PM Roth Capital Maintains TG Therapeutics (TGTX) at 'Buy' Following IRAK4 Inhibitor Compounds Presentation

Mar 5, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 3/5: (OSTK) (LL) (CP) (POWR)

Mar 4, 2015 12:21PM Streetinsider.com's Hot Lunchtime Reads 3/4: (KERX) (MCD) (RAX) (NLSN)

Mar 4, 2015 11:28AM New Checkpoint Partnership Market TG Therapeutics' (TGTX) Entry into Immuno-Oncology Segment - Roth (CNDO)

Jan 21, 2015 02:30PM Roth Affirms Curis (CRIS) at 'Buy' Following Aurigene Deal; Cuts PT to $6 on Dilution

Dec 12, 2014 02:58PM Notable 52-Week Highs and Lows 12/12: (ADBE) (MACK) (BLUE) High; (EOX) (RSH) (MCP) Low

Dec 10, 2014 10:58AM Roth Boosts PT on TG Therapeutics (TGTX) to $33 on Strong ASH Showing, Buyout Prospects

Dec 8, 2014 08:54AM TG Therapeutics's (TGTX) TGR-1202 Keeps Getting Better; Roth Affirms 'Focus Pick' Rating

Dec 1, 2014 11:46AM TG Therapeutics (TGTX) Still 'Focus Pick' at Roth; New Phase 1/1b of TGR-1202 + Imbruvica Announced

Nov 11, 2014 11:31AM Roth Positive on TG Therapeutics (TGTX) Following Q3 Results; Expects Strong ASH Showing

Nov 7, 2014 06:50AM Roth Capital Positive on TG Therapeutics (TGTX) Following Publication of ASH Abstracts

Sep 23, 2014 11:47AM Roth Comments on TG Therapeutics' (TGTX) TGR-1202 Licensing Announcement

Sep 16, 2014 10:45AM Roth Sees 'Significant' and 'Impressive' Cost Efficiencies in TG Therapeutics' (TGTX) CLL Combo Phase 3

Sep 15, 2014 01:59PM Roth Commments on TG Therapeutics (TGTX); FDA Grants TG-1101 SPA in CLL Patients

Sep 3, 2014 01:37PM Infinity (INFI) News a Positive for TG Therapeutics (TGTX) - Roth Capital

Jul 23, 2014 01:55PM Roth Sees Significant Advantages to TG Therapeutics' (TGTX) TGR-1202 vs. Gilead's (GILD) Zydelig; Reiterates 'Focus Pick' Rating

Jul 22, 2014 06:27AM Roth Capital Boosts Price Target on TG Therapeutics (TGTX) to $25 on Prelim. TG-1101 Phase 1 Data

Jun 24, 2014 09:34AM Roth 'Encouraged' by TG Therapeutics (TGTX), Ligand (LGND) Deal; Issues Commentary

Jun 13, 2014 11:13AM Roth 'Encouraged' by TG Therapeutics' (TGTX) TG-1101 Phase 2 Prelim Results; Boosts PT to $20

Jun 11, 2014 07:56AM Roth Positive on TG Therapeutics (TGTX) into EHA Presentation

Jun 2, 2014 08:19AM Roth Keeps TG Therapeutics (TGTX) as 'Focus Pick' Following ASCO Presentations

May 22, 2014 07:57AM Roth Capital Adds TG Therapeutics (TGTX) to Focus List; Sees 2014 as 'Transformational'

Mar 11, 2014 05:12PM TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor

Jul 18, 2013 08:45AM TG Therapeutics (TGTX) Prices 5.7M Common Stock Offering

Jul 17, 2013 05:53PM TG Therapeutics (TGTX) Announces Stock Offering

Mar 13, 2013 08:16AM Roth Capital Starts TG Therapeutics (TGTX) at Buy